14.84
price up icon8.24%   1.13
after-market 시간 외 거래: 14.87 0.03 +0.20%
loading
전일 마감가:
$13.71
열려 있는:
$15
하루 거래량:
2.19M
Relative Volume:
1.07
시가총액:
$2.29B
수익:
$276.98M
순이익/손실:
$-59.46M
주가수익비율:
-37.22
EPS:
-0.3987
순현금흐름:
$-48.95M
1주 성능:
+2.84%
1개월 성능:
-0.13%
6개월 성능:
-4.57%
1년 성능:
+93.61%
1일 변동 폭
Value
$14.45
$15.61
1주일 범위
Value
$13.39
$15.61
52주 변동 폭
Value
$6.7747
$20.76

Adaptive Biotechnologies Corp Stock (ADPT) Company Profile

Name
명칭
Adaptive Biotechnologies Corp
Name
전화
206-659-0067
Name
주소
1165 EASTLAKE AVE E, SEATTLE, WA
Name
직원
624
Name
트위터
@adaptivebiotech
Name
다음 수익 날짜
2025-02-11
Name
최신 SEC 제출 서류
Name
ADPT's Discussions on Twitter

Compare ADPT vs VRTX, REGN, ARGX, ALNY, ONC

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
ADPT icon
ADPT
Adaptive Biotechnologies Corp
14.84 2.11B 276.98M -59.46M -48.95M -0.3987
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
443.92 109.85B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
775.53 80.38B 14.34B 4.50B 3.77B 41.56
ARGX icon
ARGX
Argen X Se Adr
785.07 47.60B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
327.25 42.63B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
312.19 33.72B 5.36B 287.73M 924.18M 2.5229

Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-12-02 재개 Morgan Stanley Equal-Weight
2025-09-30 개시 Guggenheim Buy
2025-06-18 개시 Craig Hallum Buy
2025-03-21 업그레이드 Goldman Neutral → Buy
2023-07-05 재개 JP Morgan Overweight
2023-01-05 개시 Scotiabank Sector Outperform
2022-12-21 업그레이드 Piper Sandler Neutral → Overweight
2022-08-25 개시 Credit Suisse Underperform
2022-06-03 개시 Piper Sandler Neutral
2022-02-16 재확인 BTIG Research Buy
2022-02-16 재확인 BofA Securities Buy
2022-02-16 재확인 Goldman Neutral
2022-02-16 재확인 JP Morgan Overweight
2021-10-15 재개 Cowen Outperform
2021-03-03 다운그레이드 Goldman Buy → Neutral
2020-10-08 재개 BTIG Research Buy
2020-09-09 개시 Morgan Stanley Equal-Weight
2020-06-03 개시 Goldman Buy
2019-07-23 개시 BTIG Research Buy
2019-07-22 개시 BofA/Merrill Buy
2019-07-22 개시 Cowen Outperform
2019-07-22 개시 Goldman Neutral
2019-07-22 개시 Guggenheim Buy
2019-07-22 개시 William Blair Outperform
모두보기

Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스

pulisher
04:58 AM

Affiliate resale notice for ADPT (NASDAQ: ADPT) — 10,000 shares listed - Stock Titan

04:58 AM
pulisher
04:58 AM

ADPT (ADPT) insider Chad M. Robins sells blocks totaling six‑figure proceeds - Stock Titan

04:58 AM
pulisher
04:33 AM

ADPT (NASDAQ: ADPT) affiliate files Form 144 listing 22,564 shares for sale - Stock Titan

04:33 AM
pulisher
09:13 AM

Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On - The Motley Fool

09:13 AM
pulisher
Apr 06, 2026

Affiliate sales disclosed for Adaptive Biotechnologies (NASDAQ: ADPT) in Form 144 - Stock Titan

Apr 06, 2026
pulisher
Apr 05, 2026

Adaptive Biotechnologies Hits Day Low of $12.02 Amid Price Pressure - Markets Mojo

Apr 05, 2026
pulisher
Apr 05, 2026

A Look At Adaptive Biotechnologies (ADPT) Valuation After Q4 2025 Beat And New Pfizer Agreements - Yahoo Finance

Apr 05, 2026
pulisher
Apr 04, 2026

ADPT Technical Analysis & Stock Price Forecast - intellectia.ai

Apr 04, 2026
pulisher
Apr 03, 2026

Adaptive Biotechnologies CSO Robins sells $799k in ADPT stock - Investing.com

Apr 03, 2026
pulisher
Apr 03, 2026

Adaptive Biotechnologies CSO Robins sells $392,329 in ADPT stock - Investing.com

Apr 03, 2026
pulisher
Apr 02, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) COO Julie Rubinstein Sells 19,060 Shares - MarketBeat

Apr 02, 2026
pulisher
Apr 02, 2026

Adaptive Biotechnologies president sells $553,693 in ADPT stock - Investing.com

Apr 02, 2026
pulisher
Apr 02, 2026

Adaptive Biotechnologies (ADPT) COO exercises options and sells 38K shares - Stock Titan

Apr 02, 2026
pulisher
Apr 01, 2026

ADPT PE Ratio & Valuation, Is ADPT Overvalued - Intellectia AI

Apr 01, 2026
pulisher
Apr 01, 2026

ADPT Stock News Today | Earnings, Events & Price Alerts - intellectia.ai

Apr 01, 2026
pulisher
Mar 31, 2026

Adaptive Biotechnologies (ADPT) president sells $751k in stock By Investing.com - in.investing.com

Mar 31, 2026
pulisher
Mar 31, 2026

Adaptive Biotechnologies (ADPT) president sells $751k in stock - Investing.com

Mar 31, 2026
pulisher
Mar 31, 2026

Adaptive Biotech (NASDAQ: ADPT) COO sells 57,180 shares in 10b5-1 plan - Stock Titan

Mar 31, 2026
pulisher
Mar 30, 2026

Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look - The Motley Fool

Mar 30, 2026
pulisher
Mar 28, 2026

A Look At Adaptive Biotechnologies (ADPT) Valuation After Recent Share Price Weakness - simplywall.st

Mar 28, 2026
pulisher
Mar 27, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Trading Down 6.7%Here's What Happened - MarketBeat

Mar 27, 2026
pulisher
Mar 26, 2026

Adaptive Biotechnologies’ president Rubinstein sells $802k in ADPT stock By Investing.com - Investing.com India

Mar 26, 2026
pulisher
Mar 26, 2026

Adaptive Biotechnologies (ADPT) COO sells shares under Rule 10b5-1 plan - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

Adaptive Biotechnologies’ president Rubinstein sells $802k in ADPT stock - Investing.com

Mar 26, 2026
pulisher
Mar 26, 2026

[SCHEDULE 13G/A] Adaptive Biotechnologies Corp Amended Passive Investment Disclosure - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

Adaptive Biotechnologies (ADPT) falls 24.5% as execs dispose millions of stake - MSN

Mar 26, 2026
pulisher
Mar 26, 2026

Adaptive Biotech Insider Sale of 180,000 Shares Tied to Tax Event as Stock Jumps 70% in a Year - Yahoo Finance

Mar 26, 2026
pulisher
Mar 26, 2026

Adaptive Biotechnologies Insider Sells $1 Million in Stock After a Doubling in Share Price - Yahoo Finance

Mar 26, 2026
pulisher
Mar 24, 2026

Adaptive Biotechnologies (ADPT) president Rubinstein sells $769k in stock By Investing.com - Investing.com South Africa

Mar 24, 2026
pulisher
Mar 23, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) COO Julie Rubinstein Sells 19,060 Shares of Stock - marketbeat.com

Mar 23, 2026
pulisher
Mar 23, 2026

Adaptive Biotechnologies (ADPT) president Rubinstein sells $769k in stock - Investing.com UK

Mar 23, 2026
pulisher
Mar 23, 2026

Adaptive Biotechnologies (ADPT) COO sells 57K shares under 10b5-1 plan - Stock Titan

Mar 23, 2026
pulisher
Mar 18, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells $255,594.60 in Stock - MarketBeat

Mar 18, 2026
pulisher
Mar 18, 2026

Adaptive Biotechnologies COO Rubinstein sells $762k in ADPT stock By Investing.com - za.investing.com

Mar 18, 2026
pulisher
Mar 18, 2026

Adaptive Biotechnologies COO Rubinstein sells $762k in ADPT stock - Investing.com

Mar 18, 2026
pulisher
Mar 18, 2026

Adaptive Biotechnologies (ADPT) COO exercises options and sells 57,180 shares - Stock Titan

Mar 18, 2026
pulisher
Mar 16, 2026

[144] Adaptive Biotechnologies Corp SEC Filing - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

ADPT (NASDAQ: ADPT) lists 140,666 RSUs and 329,600 PSUs in Rule 144 filing - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

[144] Adaptive Biotechnologies Co... | ADPT SEC FilingForm 144 - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

18,672 RSUs registered for sale by filer (ADPT) via Morgan Stanley - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

Chad Robins lists multiple ADPT share sales in Form 144 (ADPT) - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Sees Unusually-High Trading VolumeHere's Why - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Adaptive Biotechnologies (ADPT) Moves 5.8% Higher: Will This Strength Last? - Yahoo Finance

Mar 16, 2026
pulisher
Mar 15, 2026

Adaptive Biotechnologies Corporation $ADPT Shares Sold by Braidwell LP - MarketBeat

Mar 15, 2026
pulisher
Mar 14, 2026

Adaptive Biotechnologies CFO Piskel sells $245,910 in shares By Investing.com - Investing.com Nigeria

Mar 14, 2026
pulisher
Mar 14, 2026

Adaptive Biotechnologies CCO Bobulsky sells $544k in ADPT stock By Investing.com - Investing.com Australia

Mar 14, 2026
pulisher
Mar 14, 2026

Insider Sell: Michelle Griffin Sells 15,394 Shares of Adaptive B - gurufocus.com

Mar 14, 2026
pulisher
Mar 13, 2026

Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) CFO Sells 18,672 Shares of Stock - MarketBeat

Mar 13, 2026

Adaptive Biotechnologies Corp (ADPT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$28.17
price up icon 1.51%
$47.90
price up icon 2.20%
$52.10
price up icon 3.97%
$92.08
price up icon 2.74%
$160.18
price down icon 1.75%
ONC ONC
$312.19
price up icon 2.75%
자본화:     |  볼륨(24시간):